| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study
|
Tang, Dominic H.
|
|
2017
|
35 |
10 |
p. 605.e17-605.e23
6.049993949999999E25 p.
|
artikel
|
| 2 |
A mouse model of bladder-specific over-expression of NOTCH2 confirms the oncogenic role of NOTCH2 in bladder cancer
|
Contreras-Sanz, Alberto
|
|
2017
|
35 |
10 |
p. 609-
1 p.
|
artikel
|
| 3 |
A normal perspective on bladder cancer
|
Southgate, Jennifer
|
|
2017
|
35 |
10 |
p. 619-
1 p.
|
artikel
|
| 4 |
Assessment of acute bowel toxicity from chemoradiation for bladder cancer using an in vivo gastrointestinal crypt assay and in vitro organoid system
|
Gorrill, Jessica
|
|
2017
|
35 |
10 |
p. 614-615
2 p.
|
artikel
|
| 5 |
Association between epithelial tumor markers’ trends during the course of treatment and oncological outcomes in urothelial bladder cancer
|
Bazargani, Soroush T.
|
|
2017
|
35 |
10 |
p. 609-611
3 p.
|
artikel
|
| 6 |
Bcl-2 as a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy
|
Turker, Polat
|
|
2017
|
35 |
10 |
p. 620-
1 p.
|
artikel
|
| 7 |
Biomarker classifiers for detection of bladder cancer in patients with haematuria are confounded by smoking and increased age
|
Simoes, Ricardo de Matos
|
|
2017
|
35 |
10 |
p. 621-
1 p.
|
artikel
|
| 8 |
CD49f labels an organoid-forming mouse urothelial cell population with stem cell features
|
Santos, Catarina P.
|
|
2017
|
35 |
10 |
p. 617-
1 p.
|
artikel
|
| 9 |
Cdk4 as therapeutic target in bladder cancer
|
Rubio, Carolina
|
|
2017
|
35 |
10 |
p. 617-
1 p.
|
artikel
|
| 10 |
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival
|
Abrahamsson, Johan
|
|
2017
|
35 |
10 |
p. 606.e9-606.e16
6.059999394E18 p.
|
artikel
|
| 11 |
Clinicopathological implications to micropapillary bladder urothelial carcinoma of the presence of sialyl Lewis X-decorated mucin 1 in stroma-facing membranes
|
Shinagawa, Tomochika
|
|
2017
|
35 |
10 |
p. 606.e17-606.e23
6.05999394E25 p.
|
artikel
|
| 12 |
Combined next generation sequencing and flow cytometry analysis of an anti-PD-L1 partial responder over time: An exploration into mechanisms of PD-L1 activity and resistance
|
Bivalacqua, Trinity J.
|
|
2017
|
35 |
10 |
p. 608-609
2 p.
|
artikel
|
| 13 |
Combined pharmacological inhibition of BRD proteins and class-I HDACs synergistically induces apoptosis in urothelial carcinoma cells
|
Hölscher, Alexander
|
|
2017
|
35 |
10 |
p. 612-613
2 p.
|
artikel
|
| 14 |
Comparison of cellular composition and Expression of PD-L1/PD1 in urine and blood cells from patients with muscle–invasive bladder cancer (MIBC) with or without neoadjuvant chemotherapy
|
Rodriguez Faba, Oscar
|
|
2017
|
35 |
10 |
p. 617-
1 p.
|
artikel
|
| 15 |
Comprehensive immune profiling of patients with urothelial carcinoma of the bladder identifies a novel immune target
|
Sfakianos, John P.
|
|
2017
|
35 |
10 |
p. 618-
1 p.
|
artikel
|
| 16 |
Correlation between Confocal laser endomicroscopy (Cellvizio®) and histological grading of upper tract urothelial carcinoma: a step forward for a better selection of patients suitable for conservative management
|
Territo, A.
|
|
2017
|
35 |
10 |
p. 616-617
2 p.
|
artikel
|
| 17 |
Cost-effectiveness of robot-assisted radical cystectomy using a propensity matched cohort
|
Baack Kukreja, Janet
|
|
2017
|
35 |
10 |
p. 616-
1 p.
|
artikel
|
| 18 |
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion
|
Bhindi, Bimal
|
|
2017
|
35 |
10 |
p. 604.e17-604.e24
6.0399993959999995E26 p.
|
artikel
|
| 19 |
Cytochrome P450 activity in muscle-invasive bladder cancer: A novel sub-group
|
Baker, Simon C.
|
|
2017
|
35 |
10 |
p. 608-
1 p.
|
artikel
|
| 20 |
Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition
|
Hau, Andrew M.
|
|
2017
|
35 |
10 |
p. 593-599
7 p.
|
artikel
|
| 21 |
Dysregulation of estrogen receptor Β pathway as a mechanism of bacillus calmette-guérin resistance in bladder cancer
|
Jalalizadeh, Mehrsa
|
|
2017
|
35 |
10 |
p. 619-
1 p.
|
artikel
|
| 22 |
Editorial Board
|
|
|
2017
|
35 |
10 |
p. i-
1 p.
|
artikel
|
| 23 |
Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma
|
Ou, Chenzhang
|
|
2017
|
35 |
10 |
p. 607.e1-607.e8
6.0699993931E10 p.
|
artikel
|
| 24 |
Follow-up of high-risk bladder cancer—Is it safe to perform fluorescence endoscopy multiple times in the same patient?
|
Apfelbeck, Maria
|
|
2017
|
35 |
10 |
p. 602.e19-602.e23
6.019398E25 p.
|
artikel
|
| 25 |
Genomic analysis of bladder cancer immunophenotypes
|
Sweis, Randy F.
|
|
2017
|
35 |
10 |
p. 619-620
2 p.
|
artikel
|
| 26 |
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment
|
Kammerer-Jacquet, Solène-Florence
|
|
2017
|
35 |
10 |
p. 603.e7-603.e14
6.029999397E16 p.
|
artikel
|
| 27 |
Histopathologic analysis of tumor bed and peritumoral pseudocapsule after in vitro tumor enucleation on radical nephrectomy specimen for clinical T1b renal cell carcinoma
|
Lu, Qun
|
|
2017
|
35 |
10 |
p. 603.e15-603.e20
6.0299397E22 p.
|
artikel
|
| 28 |
Hyperthermic intravesical chemotherapy for BCG unresponsive or BCG ineligible non-muscle invasive bladder cancer
|
de Jong, Joep J.
|
|
2017
|
35 |
10 |
p. 613-
1 p.
|
artikel
|
| 29 |
Identifying intermediate-risk candidates for active surveillance of prostate cancer
|
Savdie, Richard
|
|
2017
|
35 |
10 |
p. 605.e1-605.e8
6.0499993951E10 p.
|
artikel
|
| 30 |
Improving immune-gene therapy for bladder cancer
|
Dinney, Colin
|
|
2017
|
35 |
10 |
p. 611-
1 p.
|
artikel
|
| 31 |
Influence of renal biopsy results on the management of small kidney cancers in older patients: Results from a population-based cohort
|
Bjurlin, Marc A.
|
|
2017
|
35 |
10 |
p. 604.e1-604.e9
6.03999993961E11 p.
|
artikel
|
| 32 |
Information for Authors
|
|
|
2017
|
35 |
10 |
p. IBC-
1 p.
|
artikel
|
| 33 |
Inherent and acquired mechanisms of cisplatin resistance in long-term treated urothelial carcinoma cell lines
|
Skowron, Margaretha A.
|
|
2017
|
35 |
10 |
p. 618-
1 p.
|
artikel
|
| 34 |
Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?
|
Audenet, François
|
|
2017
|
35 |
10 |
p. 603.e1-603.e5
6.0293971E7 p.
|
artikel
|
| 35 |
Long-term survival after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis of urachal cancer
|
Mertens, Laura S.
|
|
2017
|
35 |
10 |
p. 615-616
2 p.
|
artikel
|
| 36 |
Low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naïve prostate cancer
|
Ohtaka, Mari
|
|
2017
|
35 |
10 |
p. 607.e9-607.e14
6.0699393E16 p.
|
artikel
|
| 37 |
Masthead
|
|
|
2017
|
35 |
10 |
p. IFC-
1 p.
|
artikel
|
| 38 |
Molecular characterization of field effects and their progression to clinically evident bladder cancer
|
Majewski, T.
|
|
2017
|
35 |
10 |
p. 609-
1 p.
|
artikel
|
| 39 |
Myeloid derived suppressor cells (MDSC) correlate with inflammatory biomarkers in metastatic urothelial carcinoma (mUC)
|
Grivas, Petros
|
|
2017
|
35 |
10 |
p. 611-612
2 p.
|
artikel
|
| 40 |
Non-Coding RNA modulate molecular subtype biology in muscle invasive bladder cancer (MIBC) and are independently associated with survival
|
Robertson, A. Gordon
|
|
2017
|
35 |
10 |
p. 615-
1 p.
|
artikel
|
| 41 |
PD-L1 and PD-1 expression patterns in patients with NMIBC undergoing intravesical BCG
|
Kates, Max
|
|
2017
|
35 |
10 |
p. 613-614
2 p.
|
artikel
|
| 42 |
Physical after-effects in men undergoing prostate biopsy in routine clinical practice: Results from the PiCTure study
|
Morgan, Eileen
|
|
2017
|
35 |
10 |
p. 604.e11-604.e16
6.0399396E18 p.
|
artikel
|
| 43 |
Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy
|
Seiler, Roland
|
|
2017
|
35 |
10 |
p. 618-
1 p.
|
artikel
|
| 44 |
Predictive impact of intrinsic bladder cancer subtypes on survival after radical cystectomy
|
Sundi, Debasish
|
|
2017
|
35 |
10 |
p. 619-
1 p.
|
artikel
|
| 45 |
Progression to sarcomatoid bladder cancer is associated with dysregulation of chromatin remodelling and cell cycle circuits
|
Guo, C.
|
|
2017
|
35 |
10 |
p. 612-
1 p.
|
artikel
|
| 46 |
Prospective validation of a diagnostic urine test for bladder cancer: The HEMAturia study
|
van Kessel, Kim E.M.
|
|
2017
|
35 |
10 |
p. 620-
1 p.
|
artikel
|
| 47 |
Proteomics phenotyping of bladder cancer
|
Zoidakis, Jerome
|
|
2017
|
35 |
10 |
p. 620-621
2 p.
|
artikel
|
| 48 |
Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival
|
Patel, Hiten D.
|
|
2017
|
35 |
10 |
p. 606.e1-606.e7
6.059993941E9 p.
|
artikel
|
| 49 |
Renal outcome after radical cystectomy and urinary diversion performed with restrictive hydration and vasopressor administration in the frame of an enhanced recovery program: A follow-up study of a randomized clinical trial
|
Wen Wu, Fiona Mei
|
|
2017
|
35 |
10 |
p. 602.e11-602.e17
6.0199939800000004E19 p.
|
artikel
|
| 50 |
Safety and efficacy of enzalutamide and gemcitabine and cisplatin in metastatic bladder cancer
|
Gupta, Shilpa
|
|
2017
|
35 |
10 |
p. 612-
1 p.
|
artikel
|
| 51 |
Shedding light into the role of STAG2 in urothelial bladder cancer
|
Lapi, Eleonora
|
|
2017
|
35 |
10 |
p. 615-
1 p.
|
artikel
|
| 52 |
Specific risk patterns for bladder cancer taxonomy-based subphenotypes
|
Domínguez, Sara
|
|
2017
|
35 |
10 |
p. 611-
1 p.
|
artikel
|
| 53 |
Survival differences among bladder cancer patients according to gender: Critical evaluation of radical cystectomy use and delay to treatment
|
Williams, Stephen B.
|
|
2017
|
35 |
10 |
p. 621-
1 p.
|
artikel
|
| 54 |
Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment
|
Williams, Stephen B.
|
|
2017
|
35 |
10 |
p. 602.e1-602.e9
6.01999993981E11 p.
|
artikel
|
| 55 |
Survivin and ERCC-1 expression as prognostic factor for overall survival in patients with muscle-invasive bladder cancer with and without cisplatin-based chemotherapy
|
Kiani, A.
|
|
2017
|
35 |
10 |
p. 614-
1 p.
|
artikel
|
| 56 |
Table of Contents
|
|
|
2017
|
35 |
10 |
p. ii-iv
nvt p.
|
artikel
|
| 57 |
Targeting mTOR in urothelial cancer—Beating a dead horse or ready for prime time?
|
Niegisch, Günter
|
|
2017
|
35 |
10 |
p. 600-601
2 p.
|
artikel
|
| 58 |
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens
|
Harari, Saul E.
|
|
2017
|
35 |
10 |
p. 605.e9-605.e16
6.049999395000001E18 p.
|
artikel
|
| 59 |
The retinoid system in non-muscle-invasive bladder tumors
|
Isfoss, Björn L.
|
|
2017
|
35 |
10 |
p. 613-
1 p.
|
artikel
|
| 60 |
The role of germline genetic variants in the prognosis of non-muscle invasive bladder cancer: a meta-GWAS
|
Galesloot, Tessel E.
|
|
2017
|
35 |
10 |
p. 614-
1 p.
|
artikel
|
| 61 |
Tumor-associated exosomes play a crucial role in the cell-cell communication in bladder cancer
|
Baumgart, Sophie
|
|
2017
|
35 |
10 |
p. 613-
1 p.
|
artikel
|
| 62 |
Ultrasound and the Complete Urologist Part 1: Methodology
|
Fine, Eugene M.
|
|
2017
|
35 |
10 |
p. 581-585
5 p.
|
artikel
|
| 63 |
Ultrasound and the Complete Urologist Part 2: Outcomes
|
Fine, Eugene M.
|
|
2017
|
35 |
10 |
p. 586-592
7 p.
|
artikel
|
| 64 |
Urothelial organoids: a novel culture method for bladder cancer
|
Mullenders, Jasper
|
|
2017
|
35 |
10 |
p. 616-
1 p.
|
artikel
|
| 65 |
Whole-genome gene expression analysis in urine samples of patients with prostate cancer and benign prostate hyperplasia
|
Özdemir, Taha Reşid
|
|
2017
|
35 |
10 |
p. 607.e15-607.e24
6.0699999939299997E26 p.
|
artikel
|
Tijdschrift beschrijving